Bladder cancer: epidemiology, staging and grading, and diagnosis
Z Kirkali, T Chan, M Manoharan, F Algaba, C Busch… - Urology, 2005 - Elsevier
Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the
spectrum, low-grade Ta tumors have a low progression rate and require initial endoscopic …
spectrum, low-grade Ta tumors have a low progression rate and require initial endoscopic …
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
In October 1997, Dr. FK Mostofi assembled a group of individuals interested in bladder
neoplasia at a meeting in Washington DC. The participants included urologic pathologists …
neoplasia at a meeting in Washington DC. The participants included urologic pathologists …
Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy
BWG Van Rhijn, M Burger, Y Lotan, E Solsona… - European urology, 2009 - Elsevier
CONTEXT: This review focuses on the prediction of recurrence and progression in non–
muscle invasive bladder cancer (NMIBC) and the treatments advocated for this disease …
muscle invasive bladder cancer (NMIBC) and the treatments advocated for this disease …
Staging of bladder cancer
Urothelial carcinoma of the urinary bladder is a heterogeneous disease with multiple
possible treatment modalities and a wide spectrum of clinical outcome. Treatment decisions …
possible treatment modalities and a wide spectrum of clinical outcome. Treatment decisions …
T1 bladder cancer: current considerations for diagnosis and management
B Jordan, JJ Meeks - Nature reviews urology, 2019 - nature.com
Stage T1 bladder cancers invade the lamina propria of the bladder and, despite sharing
many of the genetic features of muscle-invasive bladder cancers, are classified as non …
many of the genetic features of muscle-invasive bladder cancers, are classified as non …
Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer …
J Palou, RJ Sylvester, OR Faba, R Parada, JA Peña… - European urology, 2012 - Elsevier
BACKGROUND: Controversy exists over the most important prognostic factors in T1 high-
grade non–muscle-invasive bladder cancer (NMIBC) patients treated with bacillus Calmette …
grade non–muscle-invasive bladder cancer (NMIBC) patients treated with bacillus Calmette …
[HTML][HTML] Staging and reporting of urothelial carcinoma of the urinary bladder
Significant progress has been made in the standardization of bladder neoplasm
classification and reporting. Accurate staging using the American Joint Committee on …
classification and reporting. Accurate staging using the American Joint Committee on …
A new and highly prognostic system to discern T1 bladder cancer substage
BWG van Rhijn, TH van der Kwast, SS Alkhateeb… - European urology, 2012 - Elsevier
BACKGROUND: Management of T1 bladder cancer (BCa) is controversial. OBJECTIVE:
Evaluate the impact of substage on the clinical outcome of T1 BCa. DESIGN, SETTING, AND …
Evaluate the impact of substage on the clinical outcome of T1 BCa. DESIGN, SETTING, AND …
Contemporary management of stage T1 transitional cell carcinoma of the bladder
MS Soloway, M Sofer, A Vaidya - The Journal of urology, 2002 - Elsevier
PURPOSE: Transitional cell carcinoma involving the lamina propria (stage T1) is associated
with a high recurrence and progression rate with implications for patient survival and quality …
with a high recurrence and progression rate with implications for patient survival and quality …
The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer
E Solsona, I Iborra, R Dumont… - The Journal of …, 2000 - auajournals.org
Purpose: We analyzed the 3-month clinical response to intravesical therapy as a factor
predictive of progression in patients with high risk superficial bladder cancer. Material and …
predictive of progression in patients with high risk superficial bladder cancer. Material and …